Search

Search Constraints

You searched for: Author/Creator Sarasa, Leticia

Search Results

1. AB1601 topline results – Phase 2 study of ABvac40 in patients with amnestic mild cognitive impairment (a‐MCI) or very mild Alzheimer's Disease (Vm‐AD). (20th December 2022)

3. Detecting amyloid positivity in early Alzheimer disease using plasma biomarkers. (31st December 2021)

4. Detecting amyloid positivity in early Alzheimer's disease using combinations of plasma Aβ42/Aβ40 and p‐tau. Issue 2 (20th June 2021)

5. O1‐10‐03: an Active Anti‐AB40 Vaccine (ABVAC40) Proved to be Safe and Immunogenic in the Phase i Clinical Trial. (1st July 2016)

6. The global Alzheimer's Association round robin study on plasma amyloid β methods. Issue 1 (14th October 2021)